David Valcárcel

6.6k citations
218 papers · 5.0k · 1 hit paper · h-index 41

Impact in

  • Hematology top 0.2%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Genetics top 1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research
    • Mesenchymal stem cell research

Papers in

    • Acute Myeloid Leukemia Research 89
    • Hematopoietic Stem Cell Transplantation 86
    • Platelet Disorders and Treatments 18
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 21

David Valcárcel

206 papers receiving 4.9k citations

David Valcárcel's Hit Papers

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial 2023 · 118 citations
1180+1+2Years since publication255075100

Peers

David Valcárcel
Comparison fields: 5 of 104
  • Hematology 3.3k
  • Genetics 1.1k
  • Transplantation 218
  • Immunology 818
  • Oncology 921
Replace Christelle Ferrá with:
Christelle Ferrá Spain
R. Arnold Germany
Michele Falda Italy
Kathy Lilleby United States
Yu‐Hong Chen China
Amer Beitinjaneh United States
Brigitte Strahm Germany
H M Lazarus United States
Hiroyasu Ogawa Japan
Maurizio Musso Italy
David Valcárcel relative to Christelle Ferrá Spain Christelle Ferrá's profile →
Citations per field
00.5×2×3.4×
Christelle Ferrá · 1×
Citations per year

Countries citing papers authored by David Valcárcel

Since Specialization
Citations

This map shows the geographic impact of David Valcárcel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Valcárcel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Valcárcel more than expected).

Fields of papers citing papers by David Valcárcel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Valcárcel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Valcárcel. The network helps show where David Valcárcel may publish in the future.

Co-authors

The 25 scholars most cited alongside David Valcárcel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Valcárcel Line = papers co-authored together David Valcárcel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 218 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2013246
2 2007193
3 2011171
4 2011146
5 2015124
6
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
Hit paper breakdown →
2023118
7 2018105
8 201099
9 202298
10 200596
11 201592
12 202389
13 200681
14 202179
15 201974
16 201971
17 200370
18 200968
19 201665
20 200963

About David Valcárcel

David Valcárcel is a scholar working on Hematology, Genetics, Transplantation, Immunology and Oncology, having authored 218 papers that have together received 5.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (89 papers), Hematopoietic Stem Cell Transplantation (86 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (21 papers), Renal Transplantation Outcomes and Treatments (20 papers), Immune Cell Function and Interaction (20 papers), Platelet Disorders and Treatments (18 papers), Acute Lymphoblastic Leukemia research (16 papers) and Polyomavirus and related diseases (13 papers). The work is most often cited by research in Hematology (3.3k citations), Genetics (1.1k citations), Transplantation (218 citations), Immunology (818 citations) and Oncology (921 citations). David Valcárcel has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Jorge Sierra Gil, Rodrigo Martino, Salut Brunet, Anna Sureda, Pere Barba, Jose Luis Piñana, José Antonio Pérez‐Simón, Javier Briones, Julio Delgado and Guillermo Francisco Sanz. Their work appears in journals such as Transplantation and Cellular Therapy, Bone Marrow Transplantation, Blood, British Journal of Haematology and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact